<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335707">
  <stage>Registered</stage>
  <submitdate>13/07/2010</submitdate>
  <approvaldate>3/02/2011</approvaldate>
  <actrnumber>ACTRN12611000122954</actrnumber>
  <trial_identification>
    <studytitle>Evaluation of pulmonary function conditions pre-radiotherapy in breast cancer treatment.</studytitle>
    <scientifictitle>A single group study on early detection of functional pulmonary loss before radiotherapy on breast cancer patients.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil.</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Functional pulmonary loss.</healthcondition>
    <healthcondition>Breast cancer.</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Breast</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The patients pulmonary function was evaluated immediately before they were submitted to radiotherapy, using clinical instruments, such as incentive spirometers, manuvacuometer, peak flow, and six minute walk test. Each patient was assessed once only and the duration of the evaluation was thirty minutes.</interventions>
    <comparator>N/A this is a single group study. Each patients pulmonary function was compared to their own normative value.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Early detection / Screening</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Primary Outcome: loss of pulmonary function evaluated with incentive spirometers (IC, FVC), manuvacuometer (Pimax and Pemax.), peak flow (FP).</outcome>
      <timepoint>Timepoint: immediately before radiotherapy.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Secondary Outcome: comparing chemotherapy adjuvant and neoadjuvant influence in loss of pulmonary function evaluated with incentive spirometers (IC, FVC), manuvacuometer (Pimax and Pemax.), peak flow (FP).</outcome>
      <timepoint>Timepoint: immediately before radiotherapy.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Documented breast cancer diagnosis, operated, with radiotherapy proposition as an adjuvant treatment, after chemotherapy and/or hormone therapy neoadjuvant or adjuvant, no past or present clinical evidence of benign or malign pulmonary disease based on oncological follow up and previous history and cognitive capacity to understand simple commands and to execute tasks during testing.</inclusivecriteria>
    <inclusiveminage>35</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Women who were submitted to radiotherapy concomitant to chemotherapy were excluded from the study.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>22/04/2008</anticipatedstartdate>
    <actualstartdate>22/04/2008</actualstartdate>
    <anticipatedenddate>23/06/2009</anticipatedenddate>
    <actualenddate>23/06/2009</actualenddate>
    <samplesize>36</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state>Minas Gerais (MG)</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Renata de Carvalho Schettino</primarysponsorname>
    <primarysponsoraddress>Matipo street, 177/202 Santo Antonio cep:30350-210
BH-MG</primarysponsoraddress>
    <primarysponsorcountry>Brazil</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>unfunded</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Karla de Carvalho Schettino</sponsorname>
      <sponsoraddress>Matipo street, 177/202 Santo Antonio cep:30350-210
BH-MG</sponsoraddress>
      <sponsorcountry>Brazil</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Geovanni Dantas Cassali</sponsorname>
      <sponsoraddress>Av. Pres. Antonio Carlos 6627 Pampulha- Instituto de Ciencias Biologicas- Cep: 31270-901 BH-MG</sponsoraddress>
      <sponsorcountry>Brazil</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Miguel Torres Teixeira Leite</othercollaboratorname>
      <othercollaboratoraddress>Av. Pres. Antonio Carlos 6627 Pampulha- Instituto de Ciencias Biologicas- Cep: 31270-901 BH-MG</othercollaboratoraddress>
      <othercollaboratorcountry>Brazil</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of this study was to transversally detect, by means of routinely used physiotherapeutic instruments and a functional test, alterations in pulmonary functions due to the systemic treatments pre-radiotherapy in breast cancer treatment. Women submitted to breast cancer systemic treatments show a decrease in pulmonary function, which impairs their respiratory conditions pre-radiotherapy.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Comite de etica em pesquisa da Universidade Federal de Minas Gerais - COEP UFMG</ethicname>
      <ethicaddress>Av. Pres. Antonio Carlos 6627 Pampulha unidade Administrativa II  sala 2005 Cep: 31270-901 BH-MG</ethicaddress>
      <ethicapprovaldate>16/04/2008</ethicapprovaldate>
      <hrec>ETIC CAAE-0605.0.203.000-07</hrec>
      <ethicsubmitdate>29/11/2007</ethicsubmitdate>
      <ethiccountry>Brazil</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Mrs</title>
      <name>Renata de Carvalho Schettino</name>
      <address>Matipo street, 177/202 Santo Antonio Cep:30350-210 BH-MG</address>
      <phone>+55 31 33441161</phone>
      <fax>+55 31 34092879</fax>
      <email>renataschettino@gmail.com</email>
      <country>Brazil</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mrs</title>
      <name>Renata de Carvalho Schettino</name>
      <address>Matipo street, 177/202 Santo Antonio Cep:30350-210 BH-MG</address>
      <phone>+55 31 33441161</phone>
      <fax>+55 31 34092879</fax>
      <email>renataschettino@gmail.com</email>
      <country>Brazil</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Mrs</title>
      <name>Renata de Carvalho Schettino</name>
      <address>Matipo street, 177/202 Santo Antonio Cep:30350-210 BH-MG</address>
      <phone>+55 31 33441161</phone>
      <fax>+55 31 34092879</fax>
      <email>renataschettino@gmail.com</email>
      <country>Brazil</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Mrs</title>
      <name>Renata de Carvalho Schettino</name>
      <address>Universidade Federal de Minas Gerais (UFMG)
Rua Matipo 177/202
Bairro Santo Antonio
BH-MG
CEP 30350210
</address>
      <phone>+55 31 33441161</phone>
      <fax>+55 31 34092879</fax>
      <email>renataschettino@gmail.com</email>
      <country>Brazil</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>